Svante Bergdahl

Mortality results from the Göteborg randomised population-based prostate-cancer screening trial

Jonas Hugosson, Sigrid Carlsson, Gunnar Aus et al. · The Lancet Oncology · 2010 · 925 citations · Full text

Urology, Cancer Epidemiology, Cancer Screening +7

Infection after transrectal core biopsies of the prostate

Gunnar Aus, Göran Ahlgren, Svante Bergdahl et al. · British Journal of Urology · 1996 · 149 citations

CHARACTERISTICS OF SCREENING DETECTED PROSTATE CANCER IN MEN 50 TO 66 YEARS OLD WITH 3 TO 4 NG./ML. PROSTATE SPECIFIC ANTIGEN

P. Lodding, Gunnar Aus, Svante Bergdahl et al. · The Journal of Urology · 1998 · 141 citations

Prostate Cancer Screening Decreases the Absolute Risk of Being Diagnosed with Advanced Prostate Cancer—Results from a Prospective, Population-Based Randomized Controlled Trial

Gunnar Aus, Svante Bergdahl, Pär Lodding et al. · European Urology · 2006 · 133 citations

Urology, Cancer Epidemiology, Health Policy +12

THE RISK OF FINDING FOCAL CANCER (LESS THAN 3 MM) REMAINS HIGH ON RE-BIOPSY OF PATIENTS WITH PERSISTENTLY INCREASED PROSTATE SPECIFIC ANTIGEN BUT THE CLINICAL SIGNIFICANCE IS QUESTIONABLE

Björn Zackrisson, Gunnar Aus, Svante Bergdahl et al. · The Journal of Urology · 2004 · 54 citations